Oklahoma House · 2026 Regular Session

HB 3834: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights…

Third Reading · March 11, 2026 · Yeas 68, nays 23

How each party voted

Democrats
Yea 17 · Nay 0 · Not voting 1
Republicans
Yea 51 · Nay 23 · Not voting 7

Speaker Kyle Hilbert voted yea.

Bill

Bill
HB 3834
Motion
Third Reading
Date
March 11, 2026, 15:23
Session
2026 Regular Session
Yeas–nays
Yeas 68, nays 23; 8 didn't vote (8 excused, 0 for a conflict of interest)
Result
Passed, as the official record marks it

Official record: the Journal (PDF) ↗
The measure's page on the Legislature's site ↗

The chamber on this vote

Seats are today's members, liberal to conservative; members who have left aren't shown.

← Most liberalThe aisleMost conservative →

How each member voted

Yea (68)

Nay (23)

Excused (8)